+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Psoriatic Arthritis Drug"

Psoriatic Arthritis: Competitive Landscape to 2026 - Product Thumbnail Image

Psoriatic Arthritis: Competitive Landscape to 2026

  • Report
  • December 2018
  • 48 Pages
  • Global
From
From
From
From
From
From
From
Market Spotlight: Psoriatic Arthritis - Product Thumbnail Image

Market Spotlight: Psoriatic Arthritis

  • Report
  • September 2020
  • 65 Pages
  • Global
Psoriatic Arthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Psoriatic Arthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 355 Pages
  • Global
From
Psoriatic Arthritis Market and Forecast Analysis 2035 - Product Thumbnail Image

Psoriatic Arthritis Market and Forecast Analysis 2035

  • Drug Pipelines
  • July 2018
  • 503 Pages
  • Global
From
From
From
From
Loading Indicator

Psoriatic Arthritis Drug is a type of drug used to treat psoriatic arthritis, a type of immune disorder. It is a chronic, inflammatory condition that affects the joints and skin. Psoriatic Arthritis Drug works by targeting the underlying cause of the disease, which is an overactive immune system. It helps to reduce inflammation and pain, and can also slow down the progression of the disease. Commonly used Psoriatic Arthritis Drugs include biologics, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs). The Psoriatic Arthritis Drug market is a rapidly growing segment of the Immune Disorders Drugs market. It is driven by the increasing prevalence of psoriatic arthritis, as well as the development of new and more effective treatments. The market is expected to continue to grow in the coming years, as more treatments become available and the demand for them increases. Some of the major companies in the Psoriatic Arthritis Drug market include AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly, Janssen, Merck, Novartis, Pfizer, and Roche. Show Less Read more